Black Friday saleUp to 70% OFF
IO Biotech, Inc.IO Biotech, Inc.IO Biotech, Inc.

IO Biotech, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

IOBT chart


Full chart

IOBT upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪46.64 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.3713 USD
Net income (FY)
‪−86.08 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪44.87 M‬
Beta (1Y)
1.96

Employees


Employees (FY)
68
Change (1Y)
+11 +19.30%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.27 M‬ USD

About IO Biotech, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Mai-Britt Zocca
Website
iobiotech.com
Headquarters
Copenhagen
Founded
2014
FIGI
BBG0131XRY31
IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. Its platform is a novel approach to cancer immunotherapy designed to activate naturally occurring T cells to target immunosuppressive mechanisms. The company was founded by Mai-Britt Zocca, Inge Marie Svane, and Mads Hald Andersen in December 2014 and is headquartered in Copenhagen, Denmark.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

IOBT news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of IOBT is 0.7700 USD — it has increased by 3.80% in the past 24 hours. Watch IO Biotech, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange IO Biotech, Inc. stocks are traded under the ticker IOBT.
IOBT stock has fallen by −20.90% compared to the previous week, the month change is a −42.91% fall, over the last year IO Biotech, Inc. has showed a −27.36% decrease.
We've gathered analysts' opinions on IO Biotech, Inc. future price: according to them, IOBT price has a max estimate of 12.00 USD and a min estimate of 5.00 USD. Watch IOBT chart and read a more detailed IO Biotech, Inc. stock forecast: see what analysts think of IO Biotech, Inc. and suggest that you do with its stocks.
IOBT reached its all-time high on Nov 5, 2021 with the price of 17.8800 USD, and its all-time low was 0.6600 USD and was reached on Nov 21, 2024. View more price dynamics on IOBT chart.
See other stocks reaching their highest and lowest prices.
IOBT stock is 9.80% volatile and has beta coefficient of 1.96. Track IO Biotech, Inc. stock price on the chart and check out the list of the most volatile stocks — is IO Biotech, Inc. there?
Today IO Biotech, Inc. has the market capitalization of ‪46.64 M‬, it has decreased by −16.83% over the last week.
Yes, you can track IO Biotech, Inc. financials in yearly and quarterly reports right on TradingView.
IO Biotech, Inc. is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
IOBT earnings for the last quarter are −0.36 USD per share, whereas the estimation was −0.29 USD resulting in a −25.22% surprise. The estimated earnings for the next quarter are −0.39 USD per share. See more details about IO Biotech, Inc. earnings.
IO Biotech, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
IOBT net income for the last quarter is ‪−24.02 M‬ USD, while the quarter before that showed ‪−20.69 M‬ USD of net income which accounts for −16.09% change. Track more IO Biotech, Inc. financial stats to get the full picture.
No, IOBT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 25, 2024, the company has 68.00 employees. See our rating of the largest employees — is IO Biotech, Inc. on this list?
Like other stocks, IOBT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IO Biotech, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IO Biotech, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IO Biotech, Inc. stock shows the sell signal. See more of IO Biotech, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.